Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of LOLA on Gut Microbiome in Liver Cirrhosis
NCT05737030Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Feb 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of l-ornithine l-aspartate in Liver cirrhosis (LC), sponsored by Medical University of Graz. Started Feb 2023; status: completed.
02
Drugs
l-ornithine l-aspartate
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT05737030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05737030.